Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway

Published:2023-07-06 Issue:6 Volume:45 Page:663-671
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Li Mingming¹,Gu Kuo²,Kong Qingling¹,Wang Guonian³⁴,Gu Jing¹

Affiliation:

1. Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China

2. Department of Gastroenterology and Hepatology, The Second Hospital of Harbin, Harbin, China

3. Department of Anesthesiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China

4. Pain Research Institute of Heilongjiang Academy of Medical, Harbin, China

Funder

Haiyan Foundation of Harbin Medical University Cancer Hospital

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2023.2228476

Reference42 articles.

1. Risk Factors and Preventions of Breast Cancer

2. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets

3. Breast cancer treatment;Trayes KP;Am Fam Physician,2021

4. Breast Cancer Metastasis

5. Metastatic breast cancer;Peart O.;Radiol Technol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sufentanil Suppresses Cell Carcinogenesis Via Targeting miR-186-5p/HMGB1 Axis and Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer;Molecular Biotechnology;2024-03-12

2. Sufentanil enhances M1/M2 phenotypic polarization transition and alleviates LPS-triggered neuroinflammation in BV2 cells;Signa Vitae;2024

3. Sufentanil inhibits the invasion and epithelial-mesenchymal transition of endometrial cancer cells in vitro;European Journal of Gynaecological Oncology;2024

4. Research Progress of Opioid Analgesics;Pharmacy Information;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3